ESR1 and breast cancer: For instance, the estrogen receptor (ESR1) is a well-known bimodally expressed gene in breast cancer patients [26], and Schlafen 11 (SLFN11), a bimodal predictive genomic biomarker, predicts response to DNA-targeted chemotherapy [27].